# RAINBOW (RAINBOW) — Stock analysis

> Faxioms all-in-one stock review. Canonical page: https://faxioms.com/stocks/rainbow

## Current market snapshot

- Exchange: NSE
- Country: India
- Price: ₹1,454.7
- Change: -1.27%
- As of: 2026-09-18
- 1D return: -1.27%
- 5D return: -0.37%
- 1M return: +0.08%
- Latest complete quarter: fy27_q1

## Faxioms Analysis

_As of 2026-09-18_

### Technical Outlook

As of the close on September 17, 2026, the stock is trading at ₹1473.4. The daily timeframe shows a mixed picture, with the price above key moving averages like the 20-day EMA (₹1457.4) and 200-day SMA (₹1329.93), but below the 50-day SMA (₹1478.94). The Supertrend indicator is bearish on the daily chart, suggesting short-term caution. In contrast, the weekly and monthly timeframes present a more constructive outlook, with the price trading above multiple moving averages and the Supertrend indicator indicating a bullish trend on both longer periods. Recent patterns include an active Inside Bar on the monthly chart and a Bullish Engulfing Reversal and Outside Bar on the weekly chart, suggesting potential for continued price action.

The stock is currently positioned within its recent trading range. The nearest support is observed at ₹1473.1, just below the current price, followed by ₹1448.8. Resistance is noted at ₹1489.0, approximately 1.06% higher, and then at ₹1492.41. The annualized volatility stands at 26%, with an Average True Range (ATR) of 2.61% of the current price, indicating the typical price fluctuation range.

Key watch conditions include monitoring the price action around the ₹1489.0 resistance level. A sustained move above this could signal further upside potential, especially if confirmed by increased trading volume. Conversely, a break below the ₹1473.1 support level, particularly with higher volume, might indicate a weakening of the short-term trend.

- Current price: ₹1473.4 as of September 17, 2026.
- Daily timeframe shows mixed signals: price above some moving averages but below the 50-day SMA and under a bearish Supertrend.
- Weekly and monthly timeframes are bullish, with the price above key moving averages and Supertrend.
- Nearest support level is ₹1473.1, with resistance at ₹1489.0.
- Watch for price movement above ₹1489.0 or below ₹1473.1 for potential trend confirmation.

- Inside Bar
- Bullish Engulfing Reversal
- Outside Bar
- Doji
- Harami

### News Context

Rainbow Children's Medicare Limited announced on September 16, 2026, that its new 50-bed women's and children's hospital in Guntur, Andhra Pradesh, has commenced operations. This follows a prior disclosure on July 29, 2026, regarding the establishment of this facility. In other news, the company is scheduled to participate in three investor and analyst meetings in September 2026: the Kotak Healthcare Forum on September 18, the Anand Rathi G-200 Summit on September 21, and the J.P. Morgan Flagship India Conference on September 22. Separately, Mr. Srinath Metla resigned from his position as Chief Strategy and Growth Officer and Senior Management Personnel, effective September 5, 2026, citing personal reasons. His resignation was accepted by the company on August 31, 2026.

- On September 16, 2026, Rainbow Children's Medicare Limited reported the operational launch of its new 50-bed hospital in Guntur, Andhra Pradesh.
- The company is scheduled to participate in three investor and analyst events between September 18 and September 22, 2026.
- Mr. Srinath Metla resigned as Chief Strategy and Growth Officer and Senior Management Personnel, with his last day being September 5, 2026.

- RAINBOW: Rainbow Children's Medicare Limited has informed the Exchange about Commencement of operations at Guntur, Andhra Pradesh. |SUBJECT: General Updates
- Rainbobw Childrens Medicare Limited has informed the Exchange about Schedule of Analysts or Institutional Investors Meet |SUBJECT: Analyst/Investor Meet Para A-XBRL
- Rainbow Childrens Medicare Limited has informed the Exchange about Schedule of meet of Analyst/Institutional Investors Group Meetings. |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
- RAINBOW: Rainbow Children's Medicare Limited has informed the Exchange regarding Resignation of Mr. Srinath Metla as Senior Management Personnel of the company w.e.f. September 05, 2026. |SUBJECT: Resignation
- Rainbow Childrens Medicare Limited has informed the Exchange about Change in Directors/KMP/SMP/Auditor/RTA |SUBJECT: Change in Directors/KMP/SMP/Auditor/RTA

### What Changed

As of the report date, September 18, 2026, Rainbow Childrens Medicare's stock price has seen a slight increase, closing at ₹1473.4 on September 17, 2026, compared to its previous closing price of ₹1457.2. This represents a modest gain in the most recent trading session. The company's profile on the NSE remains unchanged, and no new filings or news developments were reported in the provided evidence pack.

- On September 17, 2026, Rainbow Childrens Medicare's stock closed at ₹1473.4.
- The previous closing price on an earlier date was ₹1457.2.
- The company is listed on the NSE.
- No new filings or news were reported as of September 18, 2026.

### Official Filings

Rainbow Children's Medicare Limited announced on September 16, 2026, that its new 50-bed women's and children's hospital in Guntur, Andhra Pradesh, has commenced operations. This follows an earlier disclosure on July 29, 2026, regarding the establishment of this facility. The company also has several investor interactions scheduled in September 2026, including the Kotak Healthcare Forum on September 18, the Anand Rathi G-200 Summit on September 21, and the J.P. Morgan Flagship India Conference on September 22. These meetings provide opportunities for the company to engage with analysts and institutional investors. Separately, the company disclosed two senior management resignations in late August 2026. Mr. Srinath Metla, Chief Strategy and Growth Officer, resigned effective September 5, 2026, due to personal reasons. Additionally, Mr. Vikas Maheshwari resigned as Chief Financial Officer and Key Managerial Personnel, also citing personal reasons, with his cessation effective August 31, 2026. The company noted that a prospective candidate for the CFO position has been identified, pending requisite formalities.

- On September 16, 2026, Rainbow Children's Medicare Limited announced the operational commencement of its new 50-bed hospital in Guntur, Andhra Pradesh.
- The company is scheduled to participate in three investor and analyst meetings in September 2026: September 18, September 21, and September 22.
- Mr. Srinath Metla resigned as Chief Strategy and Growth Officer, with his last day being September 5, 2026.
- Mr. Vikas Maheshwari resigned as Chief Financial Officer, effective August 31, 2026.
- Rainbow Children's Medicare Limited has identified a prospective candidate for the CFO position, subject to completion of formalities.

- RAINBOW: Rainbow Children's Medicare Limited has informed the Exchange about Commencement of operations at Guntur, Andhra Pradesh. |SUBJECT: General Updates
- Rainbobw Childrens Medicare Limited has informed the Exchange about Schedule of Analysts or Institutional Investors Meet |SUBJECT: Analyst/Investor Meet Para A-XBRL
- Rainbow Childrens Medicare Limited has informed the Exchange about Schedule of meet of Analyst/Institutional Investors Group Meetings. |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
- RAINBOW: Rainbow Children's Medicare Limited has informed the Exchange regarding Resignation of Mr. Srinath Metla as Senior Management Personnel of the company w.e.f. September 05, 2026. |SUBJECT: Resignation
- Rainbow Childrens Medicare Limited has informed the Exchange about Change in Directors/KMP/SMP/Auditor/RTA |SUBJECT: Change in Directors/KMP/SMP/Auditor/RTA
- Rainbow Childrens Medicare Limited has informed the Exchange about Resignation of Director/KMP/SMP |SUBJECT: Resignation of Director/KMP/SMP
- Rainbow Childrens Medicare Limited has informed the Exchange regarding Resignation of Mr Vikas Maheshwari as Chief Financial Officer of the company w.e.f. August 31, 2026. |SUBJECT: Resignation
- Rainbow Childrens Medicare Limited has informed the Exchange about Change in Directors/KMP/SMP/Auditor/RTA |SUBJECT: Change in Directors/KMP/SMP/Auditor/RTA
- Rainbow Childrens Medicare Limited has informed the Exchange about Resignation of Director/KMP/SMP |SUBJECT: Resignation of Director/KMP/SMP
- RAINBOW CHILDRENS MEDICARE LIMITED has informed the Exchange about Transcripts - earnings or quarterly calls |SUBJECT: Analyst/Investor Meet Para A-XBRL

### Fundamentals

Rainbow Children's Medicare reported revenue from operations of ₹469.99 crore in Q1 FY2026-27. This represents a sequential increase from ₹459.90 crore in Q4 FY2025-26 and ₹445.45 crore in Q3 FY2025-26. However, profit for the period saw a sequential decline, falling to ₹62.54 crore in Q1 FY2026-27 from ₹78.22 crore in Q4 FY2025-26 and ₹73.90 crore in Q3 FY2025-26. This trend is also reflected in the profit before tax, which decreased to ₹83.95 crore in Q1 FY2026-27 compared to ₹86.79 crore in Q4 FY2025-26 and ₹97.69 crore in Q3 FY2025-26. Expenses have risen over the same periods, from ₹358.27 crore in Q3 FY2025-26 to ₹398.74 crore in Q1 FY2026-27, outpacing revenue growth in the latest quarter and impacting profitability. Finance costs have remained relatively stable, around ₹20-21 crore per quarter. Basic earnings per share followed the profit trend, declining to ₹5.97 per share in Q1 FY2026-27 from ₹7.59 per share in Q4 FY2025-26.

- Revenue from operations was ₹469.99 crore in Q1 FY2026-27.
- Profit for the period declined sequentially to ₹62.54 crore in Q1 FY2026-27.
- Profit before tax decreased to ₹83.95 crore in Q1 FY2026-27.
- Expenses increased to ₹398.74 crore in Q1 FY2026-27.
- Basic earnings per share was ₹5.97 in Q1 FY2026-27.

### Bull Case

Rainbow Childrens Medicare's technical indicators show a constructive setup across multiple timeframes. The weekly trend is currently bullish, with the Super Trend indicator at 1335.41 and the 20-day Exponential Moving Average (EMA) at 1421.9, indicating upward momentum. This is further supported by a positive 6-month return of 0.31 and a year-to-date return of 0.12. While the daily trend shows a bearish Super Trend at 1541.95, the price is trading above both the 20-day and 50-day Simple Moving Averages (SMAs), with the 50-day SMA showing a positive slope of 2.68 over 5 days. The stock is also trading near its immediate support level of 1473.1.

- Weekly trend is bullish with Super Trend at 1335.41 as of the latest monthly data.
- The stock has delivered a 6-month return of 0.31 and a year-to-date return of 0.12.
- On a daily basis, the price is above the 20-day SMA (1448.24) and 50-day SMA (1478.94).
- The 50-day SMA slope is positive at 2.68 over 5 days on a daily basis.
- The current price of 1473.4 is trading near the nearest support level of 1473.1.

### Bear Case

The company's stock is currently exhibiting a bearish trend on a daily basis, as indicated by the Supertrend indicator. While the monthly trend shows a bullish signal, the daily technicals suggest potential near-term headwinds. The stock is trading close to its immediate resistance levels, with the nearest resistance identified at ₹1489.0, which is 1.06% above the current price. Furthermore, the stock has experienced a maximum drawdown of -33% and a current drawdown of -10%, indicating periods of significant price decline from its peaks.

- The daily Supertrend indicator is in a bearish state as of 2026-09-17.
- The stock's current price of ₹1473.4 is 1.06% below the nearest resistance level of ₹1489.0.
- The maximum drawdown observed for the stock is -33%.
- The current drawdown stands at -10%.

### FAQs

**What is the company's recent operational update regarding new facilities?**

On September 16, 2026, Rainbow Children's Medicare Limited announced the commencement of operations for its new 50-bed women's and children's hospital in Guntur, Andhra Pradesh. This follows an earlier disclosure on July 29, 2026, regarding the establishment of this facility.

**What is the company's recent management change?**

Mr. Srinath Metla, Chief Strategy and Growth Officer and Senior Managerial Personnel, resigned on August 31, 2026, due to personal reasons. His last working day was September 5, 2026.

**What are the company's recent investor engagement activities?**

Rainbow Children's Medicare Limited is scheduled to participate in three analyst and institutional investor meetings in September 2026: the Kotak Healthcare Forum 2026 on September 18, the Anand Rathi G-200 Summit 2026 on September 21, and the J.P. Morgan Flagship India Conference on September 22.

**How has Rainbow Children's Medicare Limited performed over different periods?**

As of September 17, 2026, the company's year-to-date return was 12%. Over the last six months, the return was 31%, while the return over the last year was 1%. The return since inception was -5%.

**What are the current technical indicators for Rainbow Children's Medicare Limited?**

As of September 17, 2026, the daily trend shows the closing price at ₹1473.4, with the 20-day Exponential Moving Average (EMA) at ₹1457.4 and the 50-day Simple Moving Average (SMA) at ₹1478.94. The Supertrend indicator is at ₹1541.95, indicating a bearish trend on a daily basis. On a monthly basis, the Supertrend is at ₹975.59, indicating a bullish trend.

- RAINBOW: Rainbow Children's Medicare Limited has informed the Exchange about Commencement of operations at Guntur, Andhra Pradesh. |SUBJECT: General Updates
- Rainbobw Childrens Medicare Limited has informed the Exchange about Schedule of Analysts or Institutional Investors Meet |SUBJECT: Analyst/Investor Meet Para A-XBRL
- Rainbow Childrens Medicare Limited has informed the Exchange about Schedule of meet of Analyst/Institutional Investors Group Meetings. |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
- RAINBOW: Rainbow Children's Medicare Limited has informed the Exchange regarding Resignation of Mr. Srinath Metla as Senior Management Personnel of the company w.e.f. September 05, 2026. |SUBJECT: Resignation
- Rainbow Childrens Medicare Limited has informed the Exchange about Change in Directors/KMP/SMP/Auditor/RTA |SUBJECT: Change in Directors/KMP/SMP/Auditor/RTA
## Technical analytics

- As of: 2026-09-18
- Daily trend: Weak Uptrend
- Weekly trend: Moderate Uptrend
- Pivot point: ₹1,476.5
- Risk regime: Price Risk Currently Contained

### Support levels
- 1419.855078125
- 1345.8117187500002
- 1315.171728515625

### Resistance levels
- 1460.9859375
- 1492.4070312499998
- 1541.15

### Return and range metrics

| Metric | Value |
| --- | --- |
| return_1 | -1.27% |
| return_10 | +0.96% |
| return_1m | -0.27% |
| return_1y | +0.40% |
| return_20 | +0.08% |
| return_3m | +0.32% |
| return_5 | -0.37% |
| return_6m | +29.43% |
| return_since_start | -6.43% |
| return_ytd | +10.59% |

### Risk and volatility metrics

| Metric | Value |
| --- | --- |
| state | contained_risk |
| label | Price risk currently contained |
| summary | Recent drawdown and price variability remain within the producer's contained-risk thresholds. |
| maximum_drawdown | -32.53% |
| annualized_volatility | +25.83% |

## Quarterly financials

- Latest complete quarter: fy27_q1

# Revenue Growth Outpaces Profit Growth, but Sequential Profit Declines on Higher Expenses

Rainbow Children's Medicare Limited reported revenue from operations of ₹469.99 crore for the quarter ended 30 June 2026, a 33.17% increase from the same period last year and a 2.19% increase from the previous quarter. Profit for the period rose 16.22% year-on-year to ₹62.54 crore, but fell 20.05% sequentially as total expenses grew faster than revenue on a quarter-on-quarter basis.

## Revenue Performance

Rainbow Children's Medicare operates a hub-and-spoke clinical model, with complex pediatric care centralized at major hospitals and linked to smaller satellite facilities. Revenue from operations for the quarter ended 30 June 2026 reached ₹469.99 crore. This represents a 33.17% increase compared to ₹352.93 crore in the year-ago quarter, and a 2.19% increase from ₹459.90 crore in the quarter ended 31 March 2026.

## Profitability and Expense Trends

Profit for the period stood at ₹62.54 crore. This is a 16.22% increase from ₹53.81 crore in the year-ago quarter. However, profit declined 20.05% sequentially from ₹78.22 crore in the previous quarter. Total expenses for the quarter were ₹398.74 crore, up 32.22% year-on-year from ₹301.57 crore and up 5.87% sequentially from ₹376.64 crore. The sequential expense growth of 5.87% outpaced the 2.19% revenue growth, compressing profitability.

Finance costs rose to ₹21.21 crore from ₹18.08 crore a year earlier, a 17.31% increase. Depreciation and amortization expense for the quarter was ₹42.20 crore. Basic earnings per share was ₹5.97, up 13.28% year-on-year from ₹5.27, but down 21.34% from ₹7.59 in the previous quarter.

## Management Commentary

Rainbow Children's Medicare reported strong Q1 FY27 results with consolidated revenue from operations rising 33% year-over-year to Rs 4,699.85 million, while consolidated profit after tax grew to Rs 625.40 million. The company is actively pursuing expansion through two key transactions: developing a new children's and women's hospital in Malad, Mumbai via its wholly owned subsidiary, and acquiring a 64% partnership interest in a running children's hospital in Nellore, Andhra Pradesh for Rs 198 million. Both transactions are expected to close in the quarter ending September 2026. Additionally, the Board approved a final dividend of Rs 3.50 per share for FY26 and elevated Mr. Anshuman Jaiswal to Chief Legal Officer, granting him 2,570 stock options under the ESOP 2025 scheme.

## Key Takeaway

Rainbow Children's Medicare delivered year-over-year revenue and profit growth, but sequential profit declined as total expenses grew faster than revenue. The quarter's expense growth outpaced revenue growth on a sequential basis, leading to lower profitability compared to the previous quarter.

### Ratios

## Official filings

- 2026-09-16 — Generic Announcement: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_16092026163154_Intimation_Guntur.pdf)
- 2026-09-11 — Generic Announcement: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_20296_WebXMLFile_20260911_145722626.xml)
- 2026-09-11 — Generic Announcement: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_11092026145514_Intimation.pdf)
- 2026-08-31 — Management Change: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_31082026171109_Intimation.pdf)
- 2026-08-31 — Generic Announcement: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/CIM_20296_WebXMLFile_20260831_171350551.xml)
- 2026-08-31 — Management Change: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOW_ROID_97453_KMP_Doc.zip)
- 2026-08-25 — Management Change: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_25082026161446_SEintimation.pdf)
- 2026-08-25 — Generic Announcement: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/CIM_20296_WebXMLFile_20260825_163912583.xml)
- 2026-08-25 — Management Change: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOW_ROID_97070_KMP_Doc.zip)
- 2026-08-04 — Generic Announcement: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_20296_WebXMLFile_20260804_145458649.xml)
- 2026-08-04 — Generic Announcement: Rainbow Children’s Medicare Limited reported a 33% year-on-year revenue growth for Q1 FY27, reaching INR 470 crores, with EBITDA growing 30% year-on-year to INR 134.6 crores. The company announced plans to add 2,500 beds over the next five years with an estimated capex of INR 2,200 crores, including a new 100-bed brownfield hospital in Malad, Mumbai, expected to open in Q1 FY28. They also acquired Prime Children's Hospital in Nellore and a 30-bed Maternal Care Block, and leased a 50-bed hospital in Guntur. — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_04082026144618_Intimationtranscript.pdf)
- 2026-07-31 — Generic Announcement: Rainbow Children’s Medicare Limited has made available the audio recording of its conference call with investors and analysts held on July 31, 2026. The call discussed the financial and operational performance for the quarter ended June 30, 2026. — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_31072026135446_Intimationaudio.pdf)
- 2026-07-31 — Generic Announcement: Rainbow Children’s Medicare Limited published its unaudited financial results for the quarter ended June 30, 2026, on July 31, 2026, in Business Standard and Mana Telangana. Tara Capital Partners India Private Limited also approved its unaudited financial results for the quarter ended June 30, 2026, on July 30, 2026. NIIF Infrastructure Finance Limited released its unaudited financial results for the quarter ended June 30, 2026, on July 30, 2026, showing a net profit of ₹134.20 crore. Incred Financial Services Limited approved its unaudited standalone financial results for the quarter ended June 30, 2026, on July 29, 2026, reporting total income of ₹75,917.02 lakhs and net profit of ₹17,167.80 lakhs. Norspin International Limited filed a Draft Red Herring Prospectus on July 29, 2026, for an initial public offering of up to 40,00,000 equity shares. — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_31072026120643_Intimationnewspaper.pdf)
- 2026-07-31 — Official Filing: Rainbow Childrens Medicare Limited has disclosed an audio recording of its earnings call for Q1 and FY 2027 on July 31, 2026. The call concluded at 11:14:00 on July 31, 2026, and the recording was uploaded to the company's website at 13:02:00 on the same date. Prior intimation of the earnings call was provided to the exchange on July 23, 2026.
- 2026-07-30 — Earnings Presentation: Rainbow Children’s Medicare Limited filed an earnings presentation on July 30, 2026, detailing un-audited financial results for the quarter ended June 30, 2026. The presentation covers standalone and consolidated financial performance and operational key performance indicators for Q1 FY27. It also outlines the company's expansion plans, including new hospital commencements and bed capacity increases across various cities through FY29. — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_30072026172956_Intimationearnigns.pdf)
- 2026-07-30 — Generic Announcement: The Board of Directors of Rainbow Children's Medicare Limited approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. Additionally, Mr. Anshuman Jaiswal was elevated from Group Head – Legal to Chief Legal Officer and designated as Senior Management Personnel, effective July 30, 2026. The company also disclosed plans for a new hospital in Malad, Mumbai, and the acquisition of a 64% partnership interest in Super Prime Medical Care LLP for Rs 198 million, both expected to complete by September 30, 2026. — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_30072026161529_Intimationoutcome.pdf)
- 2026-07-30 — Generic Announcement: The Board of Directors of Rainbow Children's Medicare Limited approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. Additionally, Mr. Anshuman Jaiswal was elevated from Group Head – Legal to Chief Legal Officer and designated as Senior Management Personnel, effective July 30, 2026. The company also disclosed plans for a new hospital in Malad, Mumbai, and the acquisition of a 64% partnership interest in Super Prime Medical Care LLP for Rs 198 million, both expected to complete by September 30, 2026. — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_30072026163244_Intimationoutcome.pdf)
- 2026-07-30 — Generic Announcement: On July 30, 2026, Rainbow Children's Medicare Limited's Nomination and Remuneration Committee granted 2,570 stock options under the ESOP 2025 to Mr. Anshuman Jaiswal. These options are exercisable into 2,570 equity shares and are priced at a discount of up to 20% from the previous day's closing price. The options will vest within one to ten years from the grant date and can be exercised within two years of vesting. — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_30072026170253_Intimationgrant.pdf)
- 2026-07-30 — Press Release: Rainbow Children’s Medicare Limited reported un-audited financial results for the quarter ended June 30, 2026, with revenue growing approximately 33% year-over-year. The company announced plans to open a 100-bed hospital in Malad, Mumbai, expected to commence operations in Q1 FY28. Additionally, Rainbow is acquiring hospitals in Nellore and Guntur, Andhra Pradesh, to expand its footprint in the region. — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_30072026173611_Intimationpress.pdf)
- 2026-07-30 — Official Filing: Rainbow Children's Medicare Limited announced the appointment of Anshuman Jaiswal as Chief Legal Officer, effective July 30, 2026. The board meeting where this decision was made took place on the same date. Jaiswal brings over two decades of legal experience, including roles at Amarchand Mangaldas and Greenko Group.
- 2026-07-30 — Generic Announcement: Rainbow Children’s Medicare Limited filed an earnings presentation on July 30, 2026, detailing un-audited financial results for the quarter ended June 30, 2026. The presentation covers standalone and consolidated financial performance and operational key performance indicators for Q1 FY27. It also outlines the company's expansion plans, including new hospital commencements and bed capacity increases across various cities through FY29. — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_30072026173138_Intimationearnigns.pdf)
- 2026-07-30 — Management Change: The Board of Directors of Rainbow Children's Medicare Limited approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. Additionally, Mr. Anshuman Jaiswal was elevated from Group Head – Legal to Chief Legal Officer and designated as Senior Management Personnel, effective July 30, 2026. The company also disclosed plans for a new hospital in Malad, Mumbai, and the acquisition of a 64% partnership interest in Super Prime Medical Care LLP for Rs 198 million, both expected to complete by September 30, 2026. — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_30072026163657_Intimationoutcome.pdf)
- 2026-07-29 — Official Filing: Rainbow Childrens Medicare Limited will transfer 2400 equity shares of its wholly owned subsidiary, Rainbow Woman and Childrens Hospital Private Limited, representing 24% of its share capital, to Fountainhead TCHM Healthcare LLP for Rs. 24,000. The transaction is expected to be completed by August 31, 2026. The subsidiary's previous year turnover, revenue, income, and net worth were all reported as zero.
- 2026-07-29 — Generic Announcement: Rainbow Children’s Medicare Limited executed a Partnership Interest and Contribution Transfer Agreement to acquire a 64% partnership interest in Super Prime Medical Care LLP for ₹19.84 Cr. This acquisition, expected to be completed by August 31, 2026, will make the LLP, which operates a 70-bed hospital in Nellore, Andhra Pradesh, a subsidiary of Rainbow Children’s Medicare Limited. The company plans to add approximately 30 beds to the hospital for gynaecology, obstetrics, and perinatal services. — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_29072026221602_Intimationnellore.pdf)
- 2026-07-29 — Official Filing: Rainbow Childrens Medicare Limited announced a capacity addition of 100 beds through the development of a children's and women's hospital in Malad, Mumbai. The project requires an investment of INR 900,000,000, to be financed through internal accruals. This new facility is expected to be commissioned by Q1 FY27-28, subject to approvals and construction completion. The company stated this addition will enhance its specialized pediatric, women, and neonatal care services in Maharashtra and complement its Pune regional hub.

## News and market events

- 2026-07-31 — CNBC-TV18: **Q1 Results LIVE Updates: Sun Pharma reports earnings; Shree Cement shares fall, GAIL up nearly 4%** — Q1 Results LIVE Updates: Four Nifty companies, ITC, Maruti Suzuki, Sun Pharma and Bajaj Finserv report results today to round off this week dominated by earnings. Broader market names like Dixon Tech, Indian Oil, Glenmark Pharma, GMDC, ABB India, SJVN, GAIL and NALCO among many others will also be reporting their results. The big result reactions of the day include the likes of Swiggy, Mazagon Dock, Thermax, Bajaj Finance's earnings call and upgrades among others. — [Source](https://www.cnbctv18.com/market/q1-results-live-updates-sun-pharma-itc-maruti-suzuki-bajaj-finserv-tata-steel-swiggy-share-price-liveblog-19958383.htm)
- 2026-07-31 — CNBC-TV18: **Sensex Today | Stock Market Live Updates: Nifty extends gains to 100 pts; PSU banks off lows** — Sensex Today | Stock Market Live Updates: We are the last half the week's trade, and the Indian markets are trading on a cautious note. The Nifty is looking to close the week in green, and is trading around 24,300. The Nifty Bank is trying to hold it together, now up around 100 points, moving around 57,250. TCS, Infosys and Wipro are the top laggards. — [Source](https://www.cnbctv18.com/market/stock-market-live-updates-sensex-nifty-50-today-it-infosys-banks-tata-steel-swiggy-sun-pharma-mdl-bajaj-fin-share-price-liveblog-19958369.htm)
- 2026-07-30 — CNBC-TV18: **Q1 Results LIVE Updates: Tata Steel profit rises 12%, JBM Auto margin expands** — Q1 Results LIVE Updates: Bajaj Finance, M&M and Tata Steel are the three Nifty results for the day, along with broader market names like Hyundai Motor, Vedanta, Vedanta Aluminium, Swiggy, Mazagon Dock, Torrent Pharma, Thermax and many others. Eicher Motors, Dabur, three Vedanta demerged units, Bajaj Housing, Hexaware and many more also react to numbers. Watch this space for all the LIVE Q1 results updates. — [Source](https://www.cnbctv18.com/market/q1-results-live-updates-today-bajaj-finance-mm-tata-steel-eicher-dabur-mazagon-dock-swiggy-syngene-irfc-vedanta-aluminium-mtar-hyundai-lic-liveblog-19957385.htm)
- 2026-07-24 — Mint: **The Street resets its Nifty 500 bets. Here are the winners** — The optimism reflects the underperformance of Indian equities relative to other emerging markets and the US, along with a moderation in valuations. — [Source](https://www.livemint.com/market/stock-market-news/the-street-resets-its-nifty-500-bets-here-are-the-winners-indian-stock-market-11784798077110.html)

## Business profile

**Strategic vision:** Specialized pediatric and obstetrics and gynecology hospital chain.

### Business segments
- **Pediatric Tertiary and Quaternary Care:** Rainbow Hospitals provide comprehensive specialized pediatric services including intensive care, sub-specialties like neurology and oncology, and pediatric surgery.
- **Obstetrics & Gynecology:** Through its 'BirthRight by Rainbow' brand, the company offers maternal care services including obstetrics, gynecology, fetal medicine, and reproductive medicine.

### Competitive strengths
- Specialized multi-specialty pediatric and obstetrics and gynecology hospital chain.
- Focus on tertiary and quaternary pediatric care and maternal health.
- Hub-and-spoke clinical model for centralized complex care and distributed outpatient services.

## Related stocks

- [360ONE (Financial Services)](https://faxioms.com/stocks/360one) — +1.11%
- [3MINDIA (Diversified)](https://faxioms.com/stocks/3mindia) — +4.81%
- [AADHARHFC](https://faxioms.com/stocks/aadharhfc) — -1.64%
- [AARTIIND](https://faxioms.com/stocks/aartiind) — +1.78%
- [AAVAS](https://faxioms.com/stocks/aavas) — -0.56%

## Freshness and sources

- Data as of: 2026-09-18
- Source: Faxioms public stock analysis API

Canonical: https://faxioms.com/stocks/rainbow
Markdown representation: https://faxioms.com/stocks/rainbow?render=md